Newsletter Subject

Re: Corona cure held hostage

From

sumofus.org

Email Address

us@sumofus.org

Sent On

Mon, Apr 6, 2020 01:20 PM

Email Preheader Text

{NAME}, did you see this? The cure for coronavirus could be held hostage by Gilead. The pharma giant

{NAME}, did you see this? The cure for coronavirus could be held hostage by Gilead. The pharma giant owns the patent for remdesivir, a drug that could be the treatment the world is waiting for. But Gilead is infamous for selling life-saving drugs at eye-watering rates that individuals and governments can’t afford. And if we let it hog this patent, it likely won’t be able to produce enough remdesivir to meet global demand. {NAME}, we can’t let Gilead get away with this -- so we’re taking this to the skies. Your donation today will pay for a plane to fly right over Gilead San Francisco HQ’s with a bold message for its CEO: “Stop trying to make a profit from the coronavirus!” Can you chip in to get this off the ground? Donating just takes a moment -- use Paypal or your card. [Yes! I'll chip in $1 to make sure coronavirus drugs will be available to all.]( Thanks for all that you do, Anne and the team at SumOfUs Here's the email I sent yesterday with more information: --------------------------------------------------------------- Pharma giant Gilead may have found the cure for coronavirus. But if we leave it up to Gilead, only the rich will be able to afford the drug. Can you chip in $1 to force Gilead to give up its monopoly and make the coronavirus treatment accessible to all? Donating just takes a moment -- use Paypal or your card. [Donate $1 now]( {NAME}, We could be close to a breakthrough in the search for a cure for the coronavirus. The most likely candidate: Gilead’s drug Remdesivir. But Gilead wants to keep exclusive control over the drug’s patent. And that’s bad news because Gilead is notorious for price gouging. It charges $1000 for a single pill of its hepatitis C drug! But here’s the good news: right now all eyes are on Gilead -- the company is extremely sensitive to public pressure. And {NAME}, this is where you come in. With your help, we’ll charter a plane to fly over Gilead's headquarters and the whole of San Francisco to send a strong message to Gilead’s bosses: “Stop trying to make a profit from the coronavirus!” We’ve found someone who can fly a plane for just under 5000 US Dollars. And this won’t just get the attention of Gilead: it will be splashed all over the news, including all the big financial newspapers -- and Gilead’s bosses and shareholders will be freaked out by this negative publicity. Donating just takes a moment -- use Paypal or your card. [Can you chip in $1 to make sure coronavirus drugs will be available to all?]( If we don’t win this and Gilead keeps exclusive rights to its drug, the treatment will be extremely expensive and out of reach for many people and countries around the world. And just as important: there won’t be enough of it for everyone. Experts say Gilead would not be able to produce the huge quantities of the drug that we need to meet global demand. The only solution is for Gilead to share its data and let other countries and manufacturers develop generic versions of the drug -- this will make it cheap and widely available. And that’s exactly what we need to save lives and beat this global pandemic. I don’t have to tell you how important this is. If Gilead keeps a monopoly, it would mean it could block generic development of the drug until 2031. 2031! That will be too late for too many people. So we'll start with the plane and won't stop until Gilead gives in -- but we can only do it with your help: Donating just takes a moment -- use Paypal or your card. [Can you chip in $1 for a free coronavirus cure for all?]( Thanks for all that you do, Anne, Christian and the whole team at SumOfUs --------------------------------------------------------------- More information: [Gilead criticised over ‘orphan status’ for potential virus treatment](. The Financial Times. 24 March 2020. [Hopes rise over experimental drug's effectiveness against coronavirus](. The Guardian. 16 March 2020. SumOfUs is a worldwide movement of people like you, working together to hold corporations accountable for their actions and forge a new, sustainable path for our global economy. This email was sent to {EMAIL}. | [Unsubscribe](

Marketing emails from sumofus.org

View More
Sent On

31/10/2023

Sent On

10/10/2023

Sent On

30/04/2023

Sent On

20/04/2023

Sent On

05/02/2023

Sent On

03/02/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.